Effect of Nurse-Directed Therapeutic Positioning in Children With Pneumonia
Effectiveness of Nurse- Directed Therapeutic Positioning on Vital Signs, Oxygen Saturation, and Respiratory Distress Severity Among Children With Pneumonia: A Comparative Study
Pneumonia is a common respiratory infection in children that may cause respiratory distress and impaired oxygenation. This quasi-experimental study aims to evaluate the effectiveness of nurse-directed therapeutic positioning on vital signs, oxygen saturation, and respiratory distress severity among children aged 3-5 years diagnosed with pneumonia. The study will compare two therapeutic positioning interventions, side-lying position and semi-Fowler's position, with a control group receiving routine nursing care. The outcomes will be assessed to determine the effects of these positioning interventions on the respiratory status of children with pneumonia.
調査の概要
状態
状態
条件
条件
介入・治療
介入・治療
研究の種類
研究の種類
入学 (推定)
入学
段階
段階
- 適用できない
連絡先と場所
研究連絡先
研究連絡先
- 名前：Nidaa H Mardan
- 電話番号：+9647807779284
- メール：nedaa.hazem2504m@conursing.uobaghdad.edu.iq
研究連絡先のバックアップ
- 名前：Adraa H Shawq, Phd
参加基準
適格基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Children aged 3-5 years.
- Children diagnosed with pneumonia.
- Children admitted to the selected pediatric hospitals.
- Children whose parents/guardians provide informed consent.
Exclusion Criteria:
- Children with chronic respiratory diseases.
- Children with congenital heart disease.
- Children with neuromuscular disorders.
- Children requiring mechanical ventilation
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：非ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
アーム数
武器と介入
参加者グループ / アーム参加者グループ / アーム |
介入・治療介入・治療 |
|---|---|
|
実験的：Side - Lying position Group
Children aged 3-5 years diagnosed with pneumonia will receive nurse-directed therapeutic positioning in the side-lying position. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol. |
Nurse-directed therapeutic positioning will be implemented for children aged 3-5 years diagnosed with pneumonia. Children assigned to this group will be placed in the side-lying position under nursing supervision, with attention to comfort, safety, and clinical tolerance. The selected side, duration of each positioning session, frequency of application, and total intervention period will be specified in the study protocol. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study's measurement schedule to evaluate changes following the intervention. |
|
実験的：Semi - Fowler's Position Group
Children aged 3-5 years diagnosed with pneumonia will receive nurse-directed therapeutic positioning in the semi-Fowler's position. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol. |
Nurse-directed therapeutic positioning will be implemented for children aged 3-5 years diagnosed with pneumonia. Children assigned to this group will be positioned in the semi-Fowler's position, with the head and upper body elevated according to the study protocol. Nursing supervision will be provided to maintain the child's comfort and safety and to monitor clinical tolerance. The elevation angle, duration of each positioning session, frequency of application, and total intervention period will be specified in the study protocol. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study's measurement schedule to evaluate changes following the intervention. |
|
介入なし：Control Group
Children aged 3-5 years diagnosed with pneumonia will receive routine nursing care according to the hospital's standard practice. Vital signs, oxygen saturation, and respiratory distress severity will be assessed according to the study protocol. |
この研究は何を測定していますか？
主要な結果の測定
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Respiratory Rate
時間枠：At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Respiratory rate will be measured in breaths per minute and compared among the semi-Fowler, side-lying, and control groups. |
At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
|
Change in Respiratory Distress Severity
時間枠：At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Respiratory distress severity will be assessed using the Clinical Respiratory Score (CRS), which consists of six parameters: respiratory rate, auscultation, use of accessory muscles, mental status, room air oxygen saturation, and skin color. Each parameter is scored from 0 to 2, yielding a total score ranging from 0 to 12. Higher scores indicate greater respiratory distress. Change in respiratory distress severity will be compared among the semi-Fowler, side-lying, and control groups. |
At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
|
Change in Peripheral Oxygen Saturation (SpO₂)
時間枠：At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Peripheral oxygen saturation will be measured using a pulse oximeter and compared among the semi-Fowler, side-lying, and control groups. |
At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
|
Change in Heart Rate
時間枠：At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
Heart rate will be measured in beats per minute and compared among the semi-Fowler, side-lying, and control groups. |
At baseline (before the application of the assigned therapeutic positioning method); and immediately after completion of the intervention.
|
協力者と研究者
捜査官
捜査官
- 主任研究者：Adraa H Shawq, Phd、University of Baghdad, College of Nursing
研究記録日
主要日程の研究
研究開始 (推定)
研究開始
一次修了 (推定)
一次修了
研究の完了 (推定)
研究の完了
試験登録日
最初に提出
最初に提出
QC基準を満たした最初の提出物
QC基準を満たした最初の提出物
最初の投稿 (実際)
最初の投稿
学習記録の更新
投稿された最後の更新 (実際)
投稿された最後の更新
QC基準を満たした最後の更新が送信されました
QC基準を満たした最後の更新が送信されました
最終確認日
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
その他の研究ID番号
- NUR-TP-PNEU
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Individual participant data will not be shared with other researchers. Data confidentiality will be maintained, and study findings will be reported in aggregate form without identifying individual participants.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。